## Abstract This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400
Adult acute lymphoblastic leukemia : Concepts and strategies
β Scribed by Stefan Faderl; Susan O'Brien; Ching-Hon Pui; Wendy Stock; Meir Wetzler; Dieter Hoelzer; Hagop M. Kantarjian
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 199 KB
- Volume
- 116
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie
## Abstract ## BACKGROUND Much progress has been made in understanding the biology of acute lymphoblastic leukemia (ALL). This has translated into the recognition of several subgroups of ALL and the institution of riskβadapted therapies. New therapies are emerging based on the definition of specif
Among 164 patients with acute lymphoblastic leukemia (ALL) (age > 11 years) induced into complete remission at four hospitals in Italy and The Netherlands between 1971-1977, 49 survived for more than three years in continuous complete remission. Features at diagnosis of the 49 long-term survivors we
Twenty-three patients (16 adults) failing their first or subsequent (n = 8) intensive treatment for de nuvo acute lymphoblastic leukemia (ALL) and chronic myeloid leukemia lymphoid blast phase (n = 2) were managed with protocol POG 8201, originally introduced in relapsed ALL of childhood. In this pr